These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28338199)

  • 1. MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
    Meng FM; Meng FM; Song XL
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):973-977. PubMed ID: 28338199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-148a represents an independent prognostic marker in bladder cancer.
    Ma L; Xu Z; Xu C; Jiang X
    Tumour Biol; 2016 Jun; 37(6):7915-20. PubMed ID: 26700670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Li M; Li BY; Xia H; Jiang LL
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
    Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of microRNA-100 in patients with bladder cancer.
    Cao YH; Zhang HH; Xu HF; Duan YJ; Li Q; Huang B
    Genet Mol Res; 2015 Dec; 14(4):15948-54. PubMed ID: 26662386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
    Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
    Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of miR-409-3p is a prognostic marker for breast cancer.
    Cao GH; Sun XL; Wu F; Chen WF; Li JQ; Hu WC
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3825-3829. PubMed ID: 27735035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of miR-342-3p in hepatocellular carcinoma tissues and its prognostic significance.
    Gao Y; Zhang SG; Wang ZH; Liao JC
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2098-2102. PubMed ID: 28537676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
    Gao Y; Liu Y; Du L; Li J; Qu A; Zhang X; Wang L; Wang C
    Med Oncol; 2015 Jan; 32(1):362. PubMed ID: 25502080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of miR-655-3p predicts worse clinical outcome in patients suffering from hepatocellular carcinoma.
    Zhao XQ; Liang B; Jiang K; Zhang HY
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):748-752. PubMed ID: 28272708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of miR-1236-3p is correlated with clinical progression and unfavorable prognosis in gastric cancer.
    Zhu XP; Wang XL; Ma J; Fang YF; Zhang HJ; Zhang C; Feng MC
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5914-5919. PubMed ID: 30280772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of miR-490-3p in osteosarcoma and its clinical significance.
    Tang B; Liu C; Zhang QM; Ni M
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):246-251. PubMed ID: 28165565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer.
    Wang S; Xue S; Dai Y; Yang J; Chen Z; Fang X; Zhou W; Wu W; Li Q
    Diagn Pathol; 2012 Nov; 7():159. PubMed ID: 23173870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
    Juracek J; Stanik M; Vesela P; Radova L; Dolezel J; Svoboda M; Slaby O
    Urol Oncol; 2019 Mar; 37(3):184.e1-184.e7. PubMed ID: 30446443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.
    Chen Z; Wu L; Lin Q; Shi J; Lin X; Shi L
    Arch Iran Med; 2016 Sep; 19(9):645-51. PubMed ID: 27631180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer.
    Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
    Cancer Biomark; 2017 Dec; 21(1):117-122. PubMed ID: 29060930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
    Ecke TH; Stier K; Weickmann S; Zhao Z; Buckendahl L; Stephan C; Kilic E; Jung K
    Cancer Med; 2017 Oct; 6(10):2252-2262. PubMed ID: 28879675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.